| Systematic (IUPAC) name | |
|---|---|
| (±)-10,11-dihydro-N,5-dimethyl-5H-dibenz[b,f]azepin-10-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Pharmacokinetic data | |
| Half-life | 7-8 hours |
| Identifiers | |
| CAS number | 21730-16-5 |
| ATC code | None |
| PubChem | CID 65700 |
| ChemSpider | 59127 |
| UNII | 303954M7YF |
| Chemical data | |
| Formula | C16H18N2 |
| Mol. mass | 238.33 g/mol |
Metapramine (trade names Prodastene, Timaxel) is a tricyclic antidepressant (TCA) which was introduced for the treatment of depression in France in 1984.[1][2] In addition to its efficacy against affective disorders, it also has analgesic properties,[3][4] and may be useful in the treatment of pain.
Metapramine has desipramine-like effects, acting as a norepinephrine reuptake inhibitor without affecting the reuptake of serotonin or dopamine.[5][6][7] It has also been shown to act as a low-affinity NMDA receptor antagonist.[8] Metapramine's direct effects on serotonin, histamine, and muscarinic acetylcholine receptors have not been assayed, but uniquely among most TCAs, it has anecdotally been reported to lack anticholinergic effects.[7][9]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
|||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)